DK0539803T3 - Triazaspirodecanon-methyl-chromaner til bekæmpelse af sygdomme i centralnervesystemet - Google Patents

Triazaspirodecanon-methyl-chromaner til bekæmpelse af sygdomme i centralnervesystemet

Info

Publication number
DK0539803T3
DK0539803T3 DK92117606T DK92117606T DK0539803T3 DK 0539803 T3 DK0539803 T3 DK 0539803T3 DK 92117606 T DK92117606 T DK 92117606T DK 92117606 T DK92117606 T DK 92117606T DK 0539803 T3 DK0539803 T3 DK 0539803T3
Authority
DK
Denmark
Prior art keywords
nervous system
central nervous
methyl
triazaspirodecanone
chromanes
Prior art date
Application number
DK92117606T
Other languages
Danish (da)
English (en)
Inventor
Hans-Georg Dr Heine
Thomas Dr Glaser
Vry Jean Marie Viktor Dr De
Rudolf Dr Schohe-Loop
Wolfgang Dr Dompert
Henning Dr Sommermeyer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0539803T3 publication Critical patent/DK0539803T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
DK92117606T 1991-10-28 1992-10-15 Triazaspirodecanon-methyl-chromaner til bekæmpelse af sygdomme i centralnervesystemet DK0539803T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4135473A DE4135473A1 (de) 1991-10-28 1991-10-28 Triazaspirodecanon-methylchromane

Publications (1)

Publication Number Publication Date
DK0539803T3 true DK0539803T3 (da) 1999-08-30

Family

ID=6443565

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92117606T DK0539803T3 (da) 1991-10-28 1992-10-15 Triazaspirodecanon-methyl-chromaner til bekæmpelse af sygdomme i centralnervesystemet

Country Status (19)

Country Link
US (1) US6060482A (fi)
EP (1) EP0539803B1 (fi)
JP (1) JP3257708B2 (fi)
KR (1) KR930007945A (fi)
AT (1) ATE175414T1 (fi)
AU (1) AU650792B2 (fi)
CA (1) CA2081256A1 (fi)
CZ (1) CZ322492A3 (fi)
DE (2) DE4135473A1 (fi)
DK (1) DK0539803T3 (fi)
ES (1) ES2125879T3 (fi)
FI (1) FI924848A (fi)
GR (1) GR3029450T3 (fi)
HU (1) HUT64068A (fi)
IL (1) IL103546A0 (fi)
MX (1) MX9205869A (fi)
NO (1) NO923974L (fi)
TW (1) TW208010B (fi)
ZA (1) ZA928290B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19522088A1 (de) * 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives
JP3989247B2 (ja) * 1999-12-06 2007-10-10 ユーロ−セルティーク エス．エイ． ノシセプチン受容体親和性を有するトリアゾスピロ化合物
US20050014818A1 (en) * 2001-11-09 2005-01-20 Masaru Mitsuda Process for producing optically active chroman derivative and intermediate
US6995168B2 (en) 2002-05-31 2006-02-07 Euro-Celtique S.A. Triazaspiro compounds useful for treating or preventing pain
CN100402529C (zh) * 2002-09-09 2008-07-16 詹森药业有限公司 用于治疗orl-1受体介导疾病的羟基烷基取代的1,3,8-三氮杂螺[4,5]癸-4-酮衍生物
CA2542626A1 (en) * 2003-10-16 2005-04-21 William R. Collier Fluid level detector and alarm apparatus
US20060178390A1 (en) * 2004-08-02 2006-08-10 Alfonzo Jordan 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
WO2008067167A1 (en) * 2006-11-28 2008-06-05 Janssen Pharmaceutica N.V. Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one
WO2008124209A1 (en) * 2007-04-09 2008-10-16 Janssen Pharmaceutica, N.V. 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826835A (en) * 1971-01-08 1974-07-30 Ciba Geigy Corp 8-benzofurylmethyl-1,3,8-triazaspiro(4,5)decanes as neuroleptics
US4826848A (en) * 1985-04-15 1989-05-02 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4689330A (en) * 1985-04-15 1987-08-25 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4957928A (en) * 1986-06-26 1990-09-18 Ciba-Geigy Corporation Hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
DE3831888A1 (de) * 1988-09-20 1990-03-29 Troponwerke Gmbh & Co Kg Arzneimittel zur behandlung von apoplexia cerebri
DE4039631A1 (de) * 1990-12-12 1992-06-17 Troponwerke Gmbh & Co Kg Neuroprotektive kombination

Also Published As

Publication number Publication date
FI924848A0 (fi) 1992-10-26
JPH05222040A (ja) 1993-08-31
NO923974D0 (no) 1992-10-13
AU650792B2 (en) 1994-06-30
IL103546A0 (en) 1993-03-15
GR3029450T3 (en) 1999-05-28
HU9203382D0 (en) 1993-01-28
DE59209607D1 (de) 1999-02-18
ES2125879T3 (es) 1999-03-16
MX9205869A (es) 1993-04-01
TW208010B (fi) 1993-06-21
EP0539803B1 (de) 1999-01-07
US6060482A (en) 2000-05-09
NO923974L (no) 1993-04-29
CA2081256A1 (en) 1993-04-29
KR930007945A (ko) 1993-05-20
EP0539803A1 (de) 1993-05-05
ATE175414T1 (de) 1999-01-15
JP3257708B2 (ja) 2002-02-18
ZA928290B (en) 1993-05-04
CZ322492A3 (en) 1993-07-14
HUT64068A (en) 1993-11-29
AU2626592A (en) 1993-04-29
DE4135473A1 (de) 1993-04-29
FI924848A (fi) 1993-04-29

Similar Documents

Publication Publication Date Title
FI925549A (fi) Nya azaheterocyklylmetyl-kromaner
DK0612322T3 (da) Fremgangsmåde til adskillelse af 5-methyl-tetrahydrofolsyre
DK0539803T3 (da) Triazaspirodecanon-methyl-chromaner til bekæmpelse af sygdomme i centralnervesystemet
ES2023509B3 (es) Producto granular (i).
DK0619806T3 (da) Fremstilling af substituerede piperidiner
NO881997D0 (no) Nye 4-benzyl-1-(2h)-ftalazinonderivater med en aminosyrerest.
ID24135A (id) Metode sintesa pirol amida
AU647612B2 (en) Novel cyclic aminophenylacetic acid derivative, production thereof, and immune response modulator containing the same as active ingredient
DE68906049D1 (de) Benzocyclohexan- und benzocycloheptan-derivate und deren salze, verfahren und zwischenprodukte zu deren herstellung, deren verwendung als heilmittel und diese enthaltende zusammensetzungen.
DE3887102T2 (de) Substituierte Derivate von 20,21-Dinoreburnamenin, Verfahren zur Herstellung und so hergestellte Zwischenprodukte, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammenstellungen.
DE3876114D1 (de) Benzodioxol-derivate, diese enthaltende zusammensetzungen und deren verwendung zur herstellung von medikamenten.
IT1312246B1 (it) Apparecchio con scacchiera fotosensibile per il comando di personalcomputer mediante emittente di luce concentrata, applicata alla testa
DK0519512T3 (da) Mikrobiologisk fremgangsmåde til fremstilling af 5-hydroxypyrazincarboxylsyre
IS3176A7 (is) Efni afleidd af Tricyclic Pyridazopyridone og aðferð til framleiðslu þeirra
DK0521766T3 (da) Hidtil ukendt fremgangsmåde til syntese af enantiomerer af 3-aminochromanderivater
IT1258788B (it) Derivati solforati di acidi biliari
ITMI920460A0 (it) Procedimento per produrre l-lisina mediante fermentazione
PT746556E (pt) Compostos triciclicos com afinidade para o receptor 5-ht1a
ATE103285T1 (de) Dihydropyridin-5-phosphonsaure zyklische ester.
ATE15671T1 (de) M-4- und isom-4-derivate, ihre herstellung und diese enthaltende zusammensetzungen.
DK0478941T3 (da) Lægemidler indeholdende substituerede 2-cyclohexen-1-yl-amin-derivater og deres anvendelse til bekæmpelse af sygdomme
IT8621840A0 (it) Composizioni farmaceutiche adattivita' sul sistema nervoso centrale.
JPS5384965A (en) Production of 1-alkyl-2-aminomethylindole derivative
ATE52028T1 (de) Verwendung eines diamins zur herstellung eines erythrozyten-weichmachers.
JPS526599A (en) Device for issuing commuters' tickets